Bah T.M., Siler D.A., Ibrahim A.H., et al. Fluid dynamics in aging-related dementias // Neurobiol Dis. 2023. Vol. 177. P. 105986. doi: 10.1016/j.nbd.2022.105986.
DOI: 10.1016/j.nbd.2022.105986

Ivanisevic J., Stauch K., Petrascheck M., et al. Metabolic drift in the aging brain // Aging (Albany NY). 2016. Vol. 8, N 5. P. 1000–1020. doi: 10.18632/aging.100961.
DOI: 10.18632/aging.100961

Iliff J.J., Lee H., Yu M., et al. Brain-wide pathway for waste clearance captured by contrast-enhanced MRI // J Clin Invest. 2013. Vol. 123, N 3, P. 1299–1309. doi: 10.1172/JCI67677.
DOI: 10.1172/JCI67677

Rasmussen M.K., Mestre H., Nedergaard M. The glymphatic pathway in neurological disorders // Lancet Neurol. 2018. Vol. 17, N 11. P. 1016–1024. doi: 10.1016/S1474-4422(18)30318-1.
DOI: 10.1016/S1474-4422(18)30318-1

Bohr T., Hjorth P.G., Holst S.C., et al. The glymphatic system: current understanding and modeling // iScience. 2022. Vol. 25, N 9. P. 104987. doi: 10.1016/j.isci.2022.104987.
DOI: 10.1016/j.isci.2022.104987

Gordleeva S., Kanakov O., Ivanchenko M., et al. Modelling the role of sleep, glymphatic system, and microglia senescence in the propagation of inflammaging // Semin Immunopathol. 2020. Vol. 42, N 5. P. 647–665. doi: 10.1007/s00281-020-00816-x.
DOI: 10.1007/s00281-020-00816-x

Jessen N.A., Munk A.S., Lundgaard I., Nedergaard M. The glymphatic system: a beginner’s guide // Neurochem Res. 2015. Vol. 40, N 12. P. 2583–2599. doi: 10.1007/s11064-015-1581-6.
DOI: 10.1007/s11064-015-1581-6

Kress B., Iliff J., Xia M., et al. Impairment of paravascular clearance pathways in the aging brain // Ann Neurol. 2014. Vol. 76, N 6. P. 845–861. doi: 10.1002/ana.24271.
DOI: 10.1002/ana.24271

Xie L., Kang H., Xu Q., et al. Sleep drives metabolite clearance from the adult brain // Science. 2013. Vol. 342, N 6156. P. 373–377. doi: 10.1126/science.1241224.
DOI: 10.1126/science.1241224

Salman M.M., Kitchen P., Iliff J.J., Bill R.M. Aquaporin 4 and glymphatic flow have central roles in brain fluid homeostasis // Nat Rev Neurosci. 2021. Vol. 22, N 10. P. 650–651. doi: 10.1038/s41583-021-00514-z.
DOI: 10.1038/s41583-021-00514-z

Shirolapov I., Zakharov A., Smirnova D., et al. Aging brain, dementia and impaired glymphatic pathway: causal relationships // Psychiatr Danub. 2023. Vol. 35, Suppl. 2. P. 236–244. PMID: 37800234

Fang Y.C., Hsieh Y.C., Hu C.J., Tu Y.K. Endothelial dysfunction in neurodegenerative diseases // Int J Mol Sci. 2023. Vol. 24, N 3. P. 2909. doi: 10.3390/ijms24032909.
DOI: 10.3390/ijms24032909

Mehta N.H., Suss R.A., Dyke J.P., et al. Quantifying cerebrospinal fluid dynamics: a review of human neuroimaging contributions to CSF physiology and neurodegenerative disease // Neurobiol Dis. 2022. Vol. 170. P. 105776. doi: 10.1016/j.nbd.2022.105776.
DOI: 10.1016/j.nbd.2022.105776

Zhou Y., Cai J., Zhang W., et al. Impairment of the glymphatic pathway and putative meningeal lymphatic vessels in the aging human // Ann Neurol. 2020. Vol. 87, N 3. P. 357–369. doi: 10.1002/ana.25670.
DOI: 10.1002/ana.25670

Широлапов И.В., Захаров А.В., Смирнова Д.А., и др. Роль глимфатического клиренса в механизмах взаимосвязи цикла сон-бодрствование и развития нейродегенеративных процессов // Журнал неврологии и психиатрии им. С.С. Корсакова. 2023. Т. 123, № 9. С. 31–36. doi: 10.17116/jnevro202312309131.
DOI: 10.17116/jnevro202312309131

Diack A.B., Alibhai J.D., Barron R., et al. Insights into mechanisms of chronic neurodegeneration // Int J Mol Sc. 2016. Vol. 17, N 1. P. 82. doi: 10.3390/ijms17010082.
DOI: 10.3390/ijms17010082

Abubakar M.B., Sanusi K.O., Ugusman A., et al. Alzheimer’s disease: an update and insights into pathophysiology // Front Aging Neurosci. 2022. Vol. 14. P. 742408. doi: 10.3389/fnagi.2022.742408.
DOI: 10.3389/fnagi.2022.742408

Chen H.L., Chen P.C., Lu C.H., et al. Associations among cognitive functions, plasma DNA, and Diffusion Tensor Image along the Perivascular Space (DTI-ALPS) in patients with Parkinson’s disease // Oxid Med Cell Longev. 2021. Vol. 2021. P. 4034509. doi: 10.1155/2021/4034509.
DOI: 10.1155/2021/4034509

Tarutani A., Adachi T., Akatsu H., et al. Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43 // Acta Neuropathol. 2022. Vol. 143. N 6. P. 613–640. Corrected and republished from: Acta Neuropathol. 2022. Vol. 144. P. 165. doi: 10.1007/s00401-022-02426-3.
DOI: 10.1007/s00401-022-02426-3

Aramadaka S., Mannam R., Sankara Narayanan R., et al. Neuroimaging in Alzheimer’s disease for early diagnosis: a comprehensive review // Cureus. 2023. Vol. 15, N 5. P. e38544. doi: 10.7759/cureus.38544.
DOI: 10.7759/cureus.38544

Sengupta U., Kayed R. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases // Prog Neurobiol. 2022. Vol. 214. P. 102270. doi: 10.1016/j.pneurobio.2022.102270.
DOI: 10.1016/j.pneurobio.2022.102270

Hernaiz A., Toivonen J.M., Bolea R., et al. Epigenetic changes in prion and prion-like neurodegenerative diseases: recent advances, potential as biomarkers and future perspectives // Int J Mol Sci. 2022. Vol. 23, N 20. P. 12609. doi: 10.3390/ijms232012609.
DOI: 10.3390/ijms232012609

Marin-Moreno A., Canoyra S., Fernández-Borges N., et al. Transgenic mouse models for the study of neurodegenerative diseases // Front Biosci (Landmark Ed). 2023. Vol. 28, N 1. P. 21. doi: 10.31083/j.fbl2801021.
DOI: 10.31083/j.fbl2801021

Li K., Wang Z. lncRNA NEAT1: key player in neurodegenerative diseases // Ageing Res Rev. 2023. Vol. 86. P. 101878. doi: 10.1016/j.arr.2023.101878.
DOI: 10.1016/j.arr.2023.101878

Huang M., Chen S. DJ-1 in neurodegenerative diseases: pathogenesis and clinical application // Prog Neurobiol. 2021. Vol. 204. P. 102114. doi: 10.1016/j.pneurobio.2021.102114.
DOI: 10.1016/j.pneurobio.2021.102114

Jack C.R. Jr., Knopman D.S., Jagust W.J., et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers // Lancet Neurol. 2013. Vol. 12, N 2. P. 207–216. doi: 10.1016/S1474-4422(12)70291-0.
DOI: 10.1016/S1474-4422(12)70291-0

Jack C.R. Jr., Wiste H.J., Weigand S.D., et al. Age, sex, and APOE ε4 effects on memory, brain structure, and beta-amyloid across the adult life span // JAMA Neurol. 2015. Vol. 72, N 5. P. 511–519. doi: 10.1001/jamaneurol.2014.4821.
DOI: 10.1001/jamaneurol.2014.4821

Carare R.O., Aldea R., Agarwal N., et al. Clearance of interstitial fluid and CSF group — part of vascular Professional Interest Area (PIA): cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer’s disease-opportunities for therapy // Alzheimers Dement (Amst). 2020. Vol. 12, N 1. P. e12053. doi: 10.1002/dad2.12053.
DOI: 10.1002/dad2.12053

Jansen W.J., Ossenkoppele R., Knol D.L., et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis // JAMA. 2015. Vol. 313, N 19. P. 1924–1938. doi: 10.1001/jama.2015.4668.
DOI: 10.1001/jama.2015.4668

Широлапов И.В., Захаров И.В., Булгакова С.В., и др. Деменция альцгеймеровского типа как следствие нарушений в глимфатической системе мозга // Психиатрия, психотерапия и клиническая психология. 2023. Т. 14, № 3. С. 291–300. doi: 10.34883/PI.2023.14.3.004.
DOI: 10.34883/PI.2023.14.3.004

Carrera-González M.D.P., Cantón-Habas V., Rich-Ruiz M. Aging, depression and dementia: the inflammatory process // Adv Clin Exp Med. 2022. Vol. 31, N 5. P. 469–473. doi: 10.17219/acem/149897.
DOI: 10.17219/acem/149897

Vargas-Sanchez K., Losada-Barragán M., Mogilevskaya M., et al. Screening for interacting proteins with peptide biomarker of blood-brain barrier alteration under inflammatory conditions // Int J Mol Sci. 2021. Vol. 22, N 9. P. 4725. doi: 10.3390/ijms22094725.
DOI: 10.3390/ijms22094725

Feng W., Zhang Y., Wang Z., et al. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer’s disease mouse model with suppression of glymphatic clearance // Alzheimers Res Ther. 2020. Vol. 12, N 1. P. 125. doi: 10.1186/s13195-020-00688-1.
DOI: 10.1186/s13195-020-00688-1

Hablitz L.M., Nedergaard M. The glymphatic system: a novel component of fundamental neurobiology // J Neurosci. 2021. Vol. 41, N 37. P. 7698–7711. doi: 10.1523/JNEUROSCI.0619-21.2021.
DOI: 10.1523/JNEUROSCI.0619-21.2021

Albargothy N.J., Johnston D.A., MacGregor-Sharp M., et al. Convective influx/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways // Acta Neuropathol. 2018. Vol. 136, N 1. P. 139–152. doi: 10.1007/s00401-018-1862-7.
DOI: 10.1007/s00401-018-1862-7

Eide P.R., Vatnehol S.A.S., Emblem K., et al. Magnetic resonance imaging provides evidence of glymphatic drainage from human brain to cervical lymph nodes // Sci Rep. 2018. Vol. 8, N 1. P. 7194. doi: 10.1038/s41598-018-25666-4.
DOI: 10.1038/s41598-018-25666-4

Keil S.A., Braun M., O’Boyle R., et al. Dynamic infrared imaging of cerebrospinal fluid tracer influx into the brain // Neurophotonics. 2022. Vol. 9, N 3. P. 031915. doi: 10.1117/1.NPh.9.3.031915.
DOI: 10.1117/1.NPh.9.3.031915

Gouveia-Freitas K., Bastos-Leite A.J. Perivascular spaces and brain waste clearance systems: relevance for neurodegenerative and cerebrovascular pathology // Neuroradiology. 2021. Vol. 63, N 10. P. 1581–1597. doi: 10.1007/s00234-021-02718-7.
DOI: 10.1007/s00234-021-02718-7

Wu C.H., Lirng J.F., Ling Y.H., et al. Noninvasive characterization of human glymphatics and meningeal lymphatics in an in vivo model of blood-brain barrier leakage // Ann Neurol. 2021. Vol. 89, N 1. P. 111–124. doi: 10.1002/ana.25928.
DOI: 10.1002/ana.25928

Nauen D.W., Troncoso J.C. Amyloid-beta is present in human lymph nodes and greatly enriched in those of the cervical region // Alzheimers Dement. 2022. Vol. 18, N 2. P. 205–210. doi: 10.1002/alz.12385.
DOI: 10.1002/alz.12385

Ishida K., Yamada K., Nishiyama R., et al. Glymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration // J Exp Med. 2022. Vol. 219, N 3. P. e20211275. doi: 10.1084/jem.20211275.
DOI: 10.1084/jem.20211275

Harrison I.F., Ismail O., Machhada A., et al. Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model // Brain. 2020. Vol. 143, N 8. P. 2576–2593. doi: 10.1093/brain/awaa179.
DOI: 10.1093/brain/awaa179

Klostranec J.M., Vucevic D., Bhatia K.D., et al. Current concepts in intracranial interstitial fluid transport and the glymphatic system: part II — imaging techniques and clinical applications // Radiology. 2021. Vol. 301, N 3. P. 516–532. doi: 10.1148/radiol.2021204088.
DOI: 10.1148/radiol.2021204088

Nedergaard M., Goldman S.A. Glymphatic failure as a final common pathway to dementia // Science. 2020. Vol. 370, N 6512. P. 50–56. doi: 10.1126/science.abb8739.
DOI: 10.1126/science.abb8739

Hladky S.B., Barrand M.A. The glymphatic hypothesis: the theory and the evidence // Fluids Barriers CNS. 2022. Vol. 19, N 1. P. 9. doi: 10.1186/s12987-021-00282-z.
DOI: 10.1186/s12987-021-00282-z

Mestre H., Hablitz L.M., Xavier A.L., et al. Aquaporin-4-dependent glymphatic solute transport in the rodent brain // Elife. 2018. Vol. 7. P. 40070. doi: 10.7554/eLife.40070.
DOI: 10.7554/eLife.40070

Zhang J., Zhao H., Xue Y., et al. Impaired glymphatic transport kinetics following induced acute ischemic brain edema in a mouse pMCAO model // Front Neurol. 2022. Vol. 13. P. 860255. Corrected and republished from: Front Neurol. 2022. Vol. 13. P. 929798. doi: 10.3389/fneur.2022.860255.
DOI: 10.3389/fneur.2022.860255

Tithof J., Boster K.A.S., Bork P.A.R., et al. Network model of glymphatic flow under different experimentally-motivated parametric scenarios // iScience. 2022. Vol. 25, N 5. P. 104258. doi: 10.1016/j.isci.2022.104258.
DOI: 10.1016/j.isci.2022.104258

Shirolapov I., Zakharov A., Gochhait S., et al. Aquaporin-4 as the main element of the glymphatic system for clearance of abnormal proteins and prevention of neurodegeneration: a review // WSEAS Transactions on Biology and Biomedicine. 2023. Vol. 20. P. 110–118. doi: 10.37394/23208.2023.20.11.
DOI: 10.37394/23208.2023.20.11

Yamada K. Multifaceted roles of aquaporins in the pathogenesis of Alzheimer’s disease // Int J Mol Sci. 2023. Vol. 24, N 7. P. 6528. doi: 10.3390/ijms24076528.
DOI: 10.3390/ijms24076528

Simon M., Wang M.X., Ismail O., et al. Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid beta plaque formation in mice // Alzheimers Res Ther. 2022. Vol. 14, N 1. P. 59. doi: 10.1186/s13195-022-00999-5.
DOI: 10.1186/s13195-022-00999-5

Wang M.X., Ray L., Tanaka K.F., et al. Varying perivascular astroglial endfoot dimensions along the vascular tree maintain perivascular-interstitial flux through the cortical mantle // Glia. 2021. Vol. 69, N 3. P. 715–728. doi: 10.1002/glia.23923.
DOI: 10.1002/glia.23923

Soden P.A., Henderson A.R., Lee E. A microfluidic model of AQP4 polarization dynamics and fluid transport in the healthy and inflamed human brain: the first step towards glymphatics-on-a-chip // Adv Biol (Weinh). 2022. Vol. 6, N 12. P. e2200027. doi: 10.1002/adbi.202200027.
DOI: 10.1002/adbi.202200027

Hajal C., Offeddu G.S., Shin Y., et al. Engineered human blood–brain barrier microfluidic model for vascular permeability analyses // Nat Protoc. 2022. Vol. 17, N 1. P. 95–128. doi: 10.1038/s41596-021-00635-w.
DOI: 10.1038/s41596-021-00635-w

Chandra A., Farrell C., Wilson H., et al. Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer’s disease spectrum // Neurobiol Aging. 2021. Vol. 97. P. 1–9. doi: 10.1016/j.neurobiolaging.2020.06.007.
DOI: 10.1016/j.neurobiolaging.2020.06.007

Kamagata K., Andica C., Takabayashi K., et al. Association of MRI indices of glymphatic system with amyloid deposition and cognition in mild cognitive impairment and Alzheimer disease // Neurology. 2022. Vol. 99, N 24. P. e2648–e2660. doi: 10.1212/WNL.0000000000201300.
DOI: 10.1212/WNL.0000000000201300

Patterson B.W., Elbert D.L., Mawuenyega K.G., et al. Age and amyloid effects on human central nervous system amyloid-beta kinetics // Ann Neurol. 2015. Vol. 78, N 3. P. 439–453. doi: 10.1002/ana.24454.
DOI: 10.1002/ana.24454

Peng S., Liu J., Liang C., et al. Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders // Neurobiol Dis. 2023. Vol. 179. P. 106035. doi: 10.1016/j.nbd.2023.106035.
DOI: 10.1016/j.nbd.2023.106035

Xu Z., Xiao N., Chen Y., et al. Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits // Mol Neurodegener. 2015. Vol. 10. P. 58. doi: 10.1186/s13024-015-0056-1.
DOI: 10.1186/s13024-015-0056-1

Peng W., Achariyar T.M., Li B., et al. Suppression of glymphatic fluid transport in a mouse model of Alzheimer’s disease // Neurobiol Dis. 2016. Vol. 93. P. 215–225. doi: 10.1016/j.nbd.2016.05.015.
DOI: 10.1016/j.nbd.2016.05.015

Zeppenfeld D.M., Simon M., Haswell J.D., et al. Association of perivascular localization of aquaporin-4 with cognition and alzheimer disease in aging brains // JAMA Neurology. 2017. Vol. 74, N 1. P. 91–99. doi: 10.1001/jamaneurol.2016.4370.
DOI: 10.1001/jamaneurol.2016.4370

Burfeind K.G., Murchison C.F., Westaway S.K., et al. The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer’s disease // Alzheimers Dement (N Y). 2017. Vol. 3, N 3. P. 348–359. doi: 10.1016/j.trci.2017.05.001.
DOI: 10.1016/j.trci.2017.05.001

Arighi A., Arcaro M., Fumagalli G.G., et al. Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation // Alzheimers Res Ther. 2022. Vol. 14, N 1. P. 135. doi: 10.1186/s13195-022-01077-6.
DOI: 10.1186/s13195-022-01077-6

Mogensen F.L., Delle C., Nedergaard M. The glymphatic system (En)during inflammation // Int J Mol Sci. 2021. Vol. 22, N 14. P. 7491. doi: 10.3390/ijms22147491.
DOI: 10.3390/ijms22147491

Verghese J.P., Terry A., de Natale E.R., Politis M. Research evidence of the role of the glymphatic system and its potential pharmacological modulation in neurodegenerative diseases // J Clin Med. 2022. Vol. 11, N 23. P. 6964. doi: 10.3390/jcm11236964.
DOI: 10.3390/jcm11236964

Alghanimy A., Martin C., Gallagher L., Holmes W.M. The effect of a novel AQP4 facilitator, TGN-073, on glymphatic transport captured by diffusion MRI and DCE-MRI // PLoS One. 2023. Vol. 18, N 3. P. 282955. doi: 10.1371/journal.pone.0282955.
DOI: 10.1371/journal.pone.0282955

Achariyar T.M., Li B., Peng W., et al. Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation // Mol Neurodegener. 2016. Vol. 11, N 1. P. 74. Corrected and republished from: Mol Neurodegener. 2017. Vol. 12. P. 3. doi: 10.1186/s13024-016-0138-8.
DOI: 10.1186/s13024-016-0138-8

Ju Y.S., Ooms S.J., Sutphen C., et al. Slow wave sleep disruption increases cerebrospinal fluid amyloid-beta levels // Brain. 2017. Vol. 140, N 8. P. 2104–2111. doi: 10.1093/brain/awx148.
DOI: 10.1093/brain/awx148

Holth J.K., Fritschi S.K., Wang C., et al. The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans // Science. 2019. Vol. 363, N 6429. P. 880–884. doi: 10.1126/science.aav2546.
DOI: 10.1126/science.aav2546

Vasciaveo V., Iadarola A., Casile A., et al. Sleep fragmentation affects glymphatic system through the different expression of AQP4 in wild type and 5xFAD mouse models // Acta Neuropathol Commun. 2023. Vol. 11, N 1. P. 16. doi: 10.1186/s40478-022-01498-2.
DOI: 10.1186/s40478-022-01498-2

Захаров А.В., Калинин В.А., Хивинцева Е.В. Нарушение сна при синуклеинопатиях // Журнал неврологии и психиатрии им. С.С. Корсакова. 2021. Т. 121, № 4, вып. 2. С. 98–102. doi: 10.17116/jnevro202112104298.
DOI: 10.17116/jnevro202112104298

Zou W., Pu T., Feng W., et al. Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein // Transl Neurodegener. 2019. Vol. 8. P. 7. doi: 10.1186/s40035-019-0147-y.
DOI: 10.1186/s40035-019-0147-y

Morawska M.M., Moreira C.G., Ginde V.R., et al. Slow-wave sleep affects synucleinopathy and regulates proteostatic processes in mouse models of Parkinson’s disease // Sci Transl Med. 2021. Vol. 13, N 623. P. eabe7099. doi: 10.1126/scitranslmed.abe7099.
DOI: 10.1126/scitranslmed.abe7099

Fultz N.E., Bonmassar G., Setsompop K., et al. Coupled electrophysiological, hemodynamic and cerebrospinal fluid oscillations in human sleep // Science. 2019. Vol. 366, N 6465. P. 628–631. doi: 10.1126/science.aax5440.
DOI: 10.1126/science.aax5440

Zakharov A.V., Khivintseva E.V., Pyatin V.F., et al. Melatonin — known and novel areas of clinical application // Neuroscience and Behavioral Physiology. 2019. Vol. 49, N 1. P. 60–63. doi: 10.1007/s11055-018-0692-3.
DOI: 10.1007/s11055-018-0692-3

Дудченко Н.Г., Чимагомедова А.Ш., Васенина Е.Е., Левин О.С. Глимфатическая система // Журнал неврологии и психиатрии им. С.С. Корсакова. 2022. Т. 122, № 7. С. 20–26. doi: 10.17116/jnevro202212207120.
DOI: 10.17116/jnevro202212207120

Buccellato F.R., D’Anca M., Serpente M., et al. The role of glymphatic system in Alzheimer’s and Parkinson’s disease pathogenesis // Biomedicines. 2022. Vol. 10, N 9. P. 2261. doi: 10.3390/biomedicines10092261.
DOI: 10.3390/biomedicines10092261

Frolov N., Pitsik E., Grubov V., et al. Perceptual integration compensates for attention deficit in elderly during repetitive auditory-based sensorimotor task // Sensors (Basel). 2023. Vol. 23, N 14. P. 6420. doi: 10.3390/s23146420.
DOI: 10.3390/s23146420

Abe Y., Ikegawa N., Yoshida K., et al. Behavioral and electrophysiological evidence for a neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice model // Acta Neuropathol Commun. 2020. Vol. 8, N 1. P. 67. doi: 10.1186/s40478-020-00936-3.
DOI: 10.1186/s40478-020-00936-3

Silva I., Silva J., Ferreira R., Trigo D. Glymphatic system, AQP4, and their implications in Alzheimer’s disease // Neurol Res Pract. 2021. Vol. 3, N 1. P. 5. doi: 10.1186/s42466-021-00102-7.
DOI: 10.1186/s42466-021-00102-7

Zhang R., Liu Y., Chen Y., et al. Aquaporin 4 deletion exacerbates brain impairments in a mouse model of chronic sleep disruption // CNS Neurosci Ther. 2020. Vol. 26, N 2. P. 228–239. doi: 10.1111/cns.13194.
DOI: 10.1111/cns.13194

Ding Z., Fan X., Zhang Y., et al. The glymphatic system: a new perspective on brain diseases // Front Aging Neurosci. 2023. Vol. 15. P. 1179988. doi: 10.3389/fnagi.2023.1179988.
DOI: 10.3389/fnagi.2023.1179988

Lohela T.J., Lilius T.O., Nedergaard M. The glymphatic system: implications for drugs for central nervous system diseases // Nat Rev Drug Discov. 2022. Vol. 21, N 10. P. 763–779. doi: 10.1038/s41573-022-00500-9.
DOI: 10.1038/s41573-022-00500-9

Spitz S., Ko E., Ertl P., Kamm R.D. How organ-on-a-chip technology can assist in studying the role of the glymphatic system in neurodegenerative diseases // Int J Mol Sci. 2023. Vol. 24, N 3. P. 2171. doi: 10.3390/ijms24032171.
DOI: 10.3390/ijms24032171